The companies said they were ready to start distributing the vaccines within a few hours of receiving the permit.
The companies said the FDA’s approval would allow the vaccine to be used in high-risk people by mid-December or the end of December.
Pfizer a BioNTech The Covid-19 vaccine has shown 95% efficacy in clinical trials.
The companies also stated that there were no serious concerns about the safety of the vaccine.
Pfizer a BioNTechIt is estimated that up to 50 million doses of the vaccine will be delivered worldwide this year, but the number of doses delivered in 2021 will reach 1.3 billion.
–